There are a number of natural and synthetic compounds that interfere with microtubule functions by binding to tubulin.1) Maytansine, rhizoxin, dolastatin 10, phomopsin A, ustiloxin A and arenastatin A are known to share the same binding site (RZX-MAY site) on to identify the common structural elements required for binding to this site. However, a common structural phomopsins (6, 7) (Figure 2)8), and it was suggested that the 13-membered cyclic core involving an aromatic ring may play an essential role in the binding to tubulin. We were therefore interested in using ustiloxin D, the simplest rhizoxin site ligand with potent anti-tubulin activity5,7), as a probe to examine the structural requirements for binding to the rhizoxin site. In the preceding paper,7) we described the preparation of ustiloxin D (4) by platinum (PtO2)-catalyzed desulfurization of ustiloxin A (1), the Fig. 2 . Structures of phomopsins A (6) and B (7).
Results and Discussion
To find the essential functional groups required for binding to tubulin, several derivatives were synthesized from ustiloxin D (4) as shown in Scheme 1. First, 4 was esterified with ethanol/0.2N hydrochloric acid to give the ethyl ester 8 in 63% yield. N-Methylation of 8 to yield 9 was performed with H2/Pd-C in methanol (20% yield).9) The ester 9 was also prepared by using CH3I/ KF-Al2O310) in CH3CN, in 45% yield from 8. OMethylation of the phenolic hydroxyl group of 8 was carried out with CH3I/Cs2CO3 in DMF to give 10 in 80% yield. The alcohol 11 was prepared by borane reduction of 4 in 70% yield. The 1H NMR data for of the hydroxy group at the C (10) position, including its removal, were also attempted, but without success.
The inhibitory activity towards microtubule assembly was evaluated for these compounds. on the activity, but is not essential, since the ester 8 and the alcohol 11 showed strong to moderate activity. (3) Alkyl substituents at the C (2) and C (6) positions on the 13-membered cyclic core seem to be important, because ustiloxin F (5) has much less activity than ustiloxin D (4)7), and the synthetic analog 15 showed no activity13). The procedures were the same as described in the previous paper.5)
Ustiloxin D Ethyl Ester (8) Thirty mg of ustiloxin D (4) was dissolved in 0.6ml of 0.2N HCl ((C2H5)2O/C2H5OH=1/4), and the solution was stirred for 18 hours at room temperature. After addition of NaHCO3 (36mg), followed by stirring for a few minutes, the solid was filtered off, and the filtrate was concentrated with a rotary evaporator. The residue was purified on a silica gel column (CH3Cl/CH3OH= 4/1), and 20mg of 8 was obtained (63% yield (i) Ustiloxin D ethyl ester (8) (1.5mg, 3mmoles) was dissolved in 0.15ml of methanol, and 3mg of 10% PdC was added to the solution with stirring. Stirring was continued under H2 at room temperature, and the N-methylation was completed within 16 hours. The catalyst was filtered off, and the filtrate was concentrated with a rotary evaporator. The residue was chromatographed on silica gel (CHCl3/CH3OH=4/1) to give 9 (0.3mg, 20% yield). (ii) A mixture of 8 (2mg), KF-Al2O310) (3mg, KF: 5 equiv. to 8), and 0.5% CH3I in CH3CN (0.1ml) (CH3I: 2 equiv. to 8) was stirred for 4 hours at room temperature. The solid was filtered off, and the filtrate was concentrated. Compound 9 was purified by silica gel TLC (CH3Cl/CH3OH=4/1). The yield of 9 was determined to be 45% from the 1H NMR spectrum. 9: FAB-MS m/z: 537 (M+H). HRFAB-MS m/z: 537.2889, Calcd for C26H41N4O8 (M+H), 537.2924. 1H NMR data are shown in Table 1. 14-O-Methyl Ustiloxin D Ethyl Ester (10) Cs2CO3 (73mg) Table 1 .
20-Hydroxymethylated
Ustiloxin D (11)
Ustiloxin D (1) (5mg, 0.01 mmole) was dissolved in tetrahydrofuran (THF) (0.5ml) and the solution was (0.5 mmoles) was added with stirring over a period of 10 minutes. After 30 minutes, the ice-bath was removed, and stirring was continued for 1 hour at room temperature. The reaction was quenched with saturated aqueous NaHCO3, and the THF was removed with a rotary evaporator. Compound 11 was purified on a CHP 20P column (50% aqueous CH3OH). 3.5mg (70% yield). 
11: FAB-MS m/z: 481 (M+H

